Has Nessa Miller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $41,107 in general payments to Nessa Miller, MD across 328 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nessa Miller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nessa Miller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nessa Miller, MD

Vascular Surgery · San Antonio, TXNPI 1477715118

Payments from drug & device makers

$41,107in general payments, 2019–2025

Across 328 payments — averaging $125.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inari Medical, Inc.$14K
Angiodynamics, Inc.$9K
Medtronic$4K
Imbed Biosciences Inc.$2K
Silk Road Medical, Inc.$2K
Penumbra, Inc.$1K
plus $10K from 42 others

What the payments were for

Consulting fees$4001%
Speaking & faculty fees$7,24418%
Travel & lodging$5,20413%
Food & beverage$22,51055%
Other$5,75014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inari Medical, Inc.	55	$13,534
Angiodynamics, Inc.	35	$8,611
Medtronic(2 entities)	48	$4,389
Imbed Biosciences Inc.	18	$1,901
Silk Road Medical, Inc.	17	$1,692
Penumbra, Inc.	9	$1,122
Veryan Medical Incorporated	11	$1,078
Boston Scientific	18	$1,065
Abiomed	9	$1,054
Shockwave Medical, Inc	8	$703
Cvrx, Inc.	4	$550
Endologix LLC	6	$541
Johnson & Johnson	15	$449
Getinge USA Sales, LLC	7	$415
Cardiovascular Systems Inc.	8	$390
Abbott	3	$380
Inspiremd Ltd	4	$353
Philips North America LLC	5	$340
Smith+Nephew	4	$256
Bard Peripheral Vascular, Inc.	4	$253
Organogenesis Inc.	2	$192
W. L. Gore & Associates, Inc.	2	$190
Biocomposites Inc	2	$150
Acera Surgical, Inc.	2	$148
Edwards Lifesciences	1	$135
Chiesi USA, Inc.	3	$116
EKOS Corporation	1	$115
Siemens Medical Solutions USA, Inc.	2	$114
Heartflow, Inc.	1	$113
Checkpoint Surgical, Inc	1	$99
Surmodics, Inc.	1	$73
Stryker	1	$62
Musculoskeletal Transplant Foundation Inc.	1	$62
Kerecis Limited	2	$58
AbbVie	3	$53
Terumo Medical Corporation	1	$43
Biotronik Inc.	1	$38
Davol Inc.	2	$37
Novartis	1	$30
Tactile Systems Technology Inc	2	$30
BD	1	$29
Integra Lifesciences Corporation	1	$26
Sirtex Medical Inc	1	$24
Argon Medical Devices, Inc.	1	$23
Elutia, Inc.	1	$21
Convatec Inc.	1	$21
Cook Medical LLC	1	$17
Teleflex LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,107 in reported general payments places this provider in the 80th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$236,414

Medicare patients

386

Services billed

1,965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	51	$45,137
ClopidogrelClopidogrel Bisulfate	49	$458

Paid to pharmacies, not to this prescriber.

Other vascular surgery in San Antonio

Lucas Ferrer CardonaSan Antonio$223K
William EnglishSan Antonio$194K
Lyssa OchoaSan Antonio$95K
Matthew SidemanSan Antonio$42K
Mazin FotehAustin$2.5M
Alan LumsdenHouston$2.4M
Gregory PearlDallas$2.3M
Gustavo OderichHouston$999K
Michael SiahDallas$838K
Stephen HohmannDallas$587K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →